PillLorazepam
Brands: Ativan · Lorazepam
4 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | unknown | 13 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 2 | SUPPLYING |
| Civica, Inc. | unknown | 1 | SUPPLYING |
| International Medication Systems, Limited | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jul 22, 2025RECALLRecall (Class II): Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, …
Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds — Recalling firm: Hikma Pharmaceuticals USA Inc. — Distributed Nationwide in the USA
- May 11, 2023RECALLRecall (Class II): Lorazepam Injection, USP, 2mg/mL, 1 mL vial (NDC 0641-6044-01), packaged in 25 x 1 mL Vials per carton (NDC 0641-6044-2…
Failed Impurities/Degradation Specifications: Out-of-specification results for total related compounds observed during retain steting due to the elevated Related Compound-C. — Recalling firm: Hikma Pharmaceuticals USA Inc. — Nationwide in the USA and Puerto Rico
- Jul 11, 2022RECALLRecall (Class II): Lorazepam Injection, USP, 4mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by Hikma Berkeley Hei…
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples. — Recalling firm: Hikma Pharmaceuticals USA Inc. — Nationwide in the USA
- Jul 11, 2022RECALLRecall (Class II): Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by Hikma Berkeley Hei…
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples. — Recalling firm: Hikma Pharmaceuticals USA Inc. — Nationwide in the USA
- Jul 11, 2022RECALLRecall (Class II): Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured by West-Ward Eatontown, NJ 077…
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples. — Recalling firm: Hikma Pharmaceuticals USA Inc. — Nationwide in the USA
- Jul 11, 2022RECALLRecall (Class II): Ativan Injection (lorazepam injection, USP), 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured by West-War…
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples. — Recalling firm: Hikma Pharmaceuticals USA Inc. — Nationwide in the USA
- May 3, 2018SHORTAGEDrug shortage: Lorazepam Injection (Amphastar Pharmaceuticals, Inc.)
Lorazepam Injection — reported in shortage by Amphastar Pharmaceuticals, Inc.. Therapeutic category: Neurology.
- May 3, 2018SHORTAGEDrug shortage: Lorazepam Injection (Fresenius Kabi USA, LLC)
Lorazepam Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Neurology.
- May 3, 2018SHORTAGEDrug shortage: Lorazepam Injection (Hikma Pharmaceuticals USA, Inc.)
Lorazepam Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Neurology.